N/A
20 Years
70 Years
20 Years
70 Years
Open (Enrolling)
Both
The Patients With Gastric Cancer Who Are Scheduled to Receive Laparoscopy Assisted Gastrectomy
Both
The Patients With Gastric Cancer Who Are Scheduled to Receive Laparoscopy Assisted Gastrectomy
Trial Information
Inclusion Criteria:
- Age between 20 and 70
- ASA class I and II
- Gastric cancer patients who are scheduled to receive laparoscopic gastrectomy
Exclusion Criteria:
- Cardiovascular disease(uncontrolled hypertension, unstable angina, congestive heart
failure, etc.)
- Renal failure
- Liver failure
- Chronic drug or alcohol abuser
- Anti-cancer chemotherapy
- Chronic opioid use
- Use of antiemetics within 24hrs for nausea and vomiting
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
Pain score(VAS) within 48hrs after surgery
Outcome Description:
Pain score after surgery within 48hrs after laparoscopic gastrectomy
Outcome Time Frame:
Pain socre after surgery 1) within 30min-6hrs, 2) within 6-24hrs, 3) within 24hrs-48hrs
Safety Issue:
No
Authority:
South Korea: Korea Food and Drug Administration (KFDA)
Study ID:
4-2013-0176
NCT ID:
NCT01863355
Start Date:
May 2013
Completion Date:
December 2014
Related Keywords:
- The Patients With Gastric Cancer Who Are Scheduled to Receive Laparoscopy Assisted Gastrectomy
- IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy
- Stomach Neoplasms
Name | Location |
|---|
